{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:05:06Z","timestamp":1768485906004,"version":"3.49.0"},"update-to":[{"DOI":"10.1371\/journal.pcbi.1012068","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000}}],"reference-count":47,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T00:00:00Z","timestamp":1714348800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["62072277"],"award-info":[{"award-number":["62072277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61972257"],"award-info":[{"award-number":["61972257"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["61877064"],"award-info":[{"award-number":["61877064"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.ploscompbiol.org"],"crossmark-restriction":false},"short-container-title":["PLoS Comput Biol"],"abstract":"<jats:p>Cancer development is driven by an accumulation of a small number of driver genetic mutations that confer the selective growth advantage to the cell, while most passenger mutations do not contribute to tumor progression. The identification of these driver genes responsible for tumorigenesis is a crucial step in designing effective cancer treatments. Although many computational methods have been developed with this purpose, the majority of existing methods solely provided a single driver gene list for the entire cohort of patients, ignoring the high heterogeneity of driver events across patients. It remains challenging to identify the personalized driver genes. Here, we propose a novel method (PDRWH), which aims to prioritize the mutated genes of a single patient based on their impact on the abnormal expression of downstream genes across a group of patients who share the co-mutation genes and similar gene expression profiles. The wide experimental results on 16 cancer datasets from TCGA showed that PDRWH excels in identifying known general driver genes and tumor-specific drivers. In the comparative testing across five cancer types, PDRWH outperformed existing individual-level methods as well as cohort-level methods. Our results also demonstrated that PDRWH could identify both common and rare drivers. The personalized driver profiles could improve tumor stratification, providing new insights into understanding tumor heterogeneity and taking a further step toward personalized treatment. We also validated one of our predicted novel personalized driver genes on tumor cell proliferation by vitro cell-based assays, the promoting effect of the high expression of Low-density lipoprotein receptor-related protein 1 (<jats:italic>LRP1<\/jats:italic>) on tumor cell proliferation.<\/jats:p>","DOI":"10.1371\/journal.pcbi.1012068","type":"journal-article","created":{"date-parts":[[2024,4,29]],"date-time":"2024-04-29T17:39:01Z","timestamp":1714412341000},"page":"e1012068","update-policy":"https:\/\/doi.org\/10.1371\/journal.pcbi.corrections_policy","source":"Crossref","is-referenced-by-count":5,"title":["A novel hypergraph model for identifying and prioritizing personalized drivers in cancer"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0800-0016","authenticated-orcid":true,"given":"Naiqian","family":"Zhang","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7372-1800","authenticated-orcid":true,"given":"Fubin","family":"Ma","sequence":"additional","affiliation":[]},{"given":"Dong","family":"Guo","sequence":"additional","affiliation":[]},{"given":"Yuxuan","family":"Pang","sequence":"additional","affiliation":[]},{"given":"Chenye","family":"Wang","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3842-1153","authenticated-orcid":true,"given":"Yusen","family":"Zhang","sequence":"additional","affiliation":[]},{"given":"Xiaoqi","family":"Zheng","sequence":"additional","affiliation":[]},{"given":"Mingyi","family":"Wang","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2024,4,29]]},"reference":[{"issue":"3","key":"pcbi.1012068.ref001","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"H Sung","year":"2021","journal-title":"Ca-a Cancer Journal for Clinicians"},{"key":"pcbi.1012068.ref002","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fgene.2017.00083","article-title":"Computational Methods for Characterizing Cancer Mutational Heterogeneity","volume":"8","author":"F. Vandin","year":"2017","journal-title":"Frontiers in genetics"},{"issue":"4","key":"pcbi.1012068.ref003","first-page":"611","article-title":"Transposable elements drive widespread expression of oncogenes in human cancers","volume":"51","author":"HS Jang","year":"2019"},{"issue":"11","key":"pcbi.1012068.ref004","first-page":"5553","article-title":"Computational methods for cancer driver discovery: A survey","volume":"11","author":"VVH Pham","year":"2021"},{"issue":"20","key":"pcbi.1012068.ref005","first-page":"1895","article-title":"The path to cancer\u2014three strikes and you\u2019re out","volume":"373","author":"B Vogelstein","year":"2015"},{"issue":"1","key":"pcbi.1012068.ref006","first-page":"17","article-title":"Lessons from the cancer genome","volume":"153","author":"LA Garraway","year":"2013"},{"issue":"23","key":"pcbi.1012068.ref007","first-page":"2209","article-title":"Genomic classification and prognosis in acute myeloid leukemia","volume":"374","author":"E Papaemmanuil","year":"2016"},{"issue":"4","key":"pcbi.1012068.ref008","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41587-019-0055-9","article-title":"The International Cancer Genome Consortium Data Portal","volume":"37","author":"JJ Zhang","year":"2019","journal-title":"Nature Biotechnology"},{"issue":"1","key":"pcbi.1012068.ref009","first-page":"1","article-title":"Identifying driver mutations in sequenced cancer genomes: computational approaches to enable precision medicine","volume":"6","author":"BJ Raphael","year":"2014"},{"issue":"1A","key":"pcbi.1012068.ref010","first-page":"A68","article-title":"The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge","volume":"19","author":"K Tomczak","year":"2015","journal-title":"Contemp Oncol (Pozn)"},{"issue":"7457","key":"pcbi.1012068.ref011","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"MS Lawrence","year":"2013","journal-title":"Nature"},{"issue":"17","key":"pcbi.1012068.ref012","first-page":"i572","article-title":"ContrastRank: a new method for ranking putative cancer driver genes and classification of tumor samples","volume":"30","author":"R Tian","year":"2014"},{"issue":"8","key":"pcbi.1012068.ref013","article-title":"DriverML: a machine learning algorithm for identifying driver genes in cancer sequencing studies","volume":"47","author":"Y Han","year":"2019","journal-title":"Nucleic Acids Research"},{"issue":"2","key":"pcbi.1012068.ref014","first-page":"106","article-title":"Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes","volume":"47","author":"MD Leiserson","year":"2015"},{"issue":"11","key":"pcbi.1012068.ref015","first-page":"1108","article-title":"Network-based stratification of tumor mutations","volume":"10","author":"M Hofree","year":"2013"},{"issue":"19","key":"pcbi.1012068.ref016","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1093\/bioinformatics\/btab262","article-title":"pDriver: a novel method for unravelling personalized coding and miRNA cancer drivers","volume":"37","author":"VVH Pham","year":"2021","journal-title":"Bioinformatics"},{"issue":"7768","key":"pcbi.1012068.ref017","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41586-019-1373-2","article-title":"A human liver cell atlas reveals heterogeneity and epithelial progenitors","volume":"572","author":"N Aizarani","year":"2019","journal-title":"Nature"},{"issue":"7","key":"pcbi.1012068.ref018","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-014-0056-8","article-title":"DawnRank: discovering personalized driver genes in cancer","volume":"6","author":"JP Hou","year":"2014","journal-title":"Genome Med"},{"issue":"6","key":"pcbi.1012068.ref019","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/bioinformatics\/btz815","article-title":"PRODIGY: personalized prioritization of driver genes","volume":"36","author":"G Dinstag","year":"2020","journal-title":"Bioinformatics"},{"issue":"11","key":"pcbi.1012068.ref020","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1093\/bioinformatics\/bty006","article-title":"Discovering personalized driver mutation profiles of single samples in cancer by network control strategy","volume":"34","author":"WF Guo","year":"2018","journal-title":"Bioinformatics"},{"key":"pcbi.1012068.ref021","article-title":"PersonaDrive: A Method for the Identification and Prioritization of Personalized Cancer Drivers","author":"C Erten","year":"2022","journal-title":"Bioinformatics"},{"issue":"9","key":"pcbi.1012068.ref022","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.trecan.2021.04.009","article-title":"Co-occurrence and mutual exclusivity: what cross-cancer mutation patterns can tell us","volume":"7","author":"G El Tekle","year":"2021","journal-title":"Trends Cancer"},{"issue":"2","key":"pcbi.1012068.ref023","first-page":"415","article-title":"Comprehensive Analysis of Co-Mutations Identifies Cooperating Mechanisms of Tumorigenesis","volume":"14","author":"L Jiang","year":"2022"},{"key":"pcbi.1012068.ref024","volume-title":"Hypergraph Theory: An Introduction. 1st 2013. ed.","author":"SpringerLink","year":"2013"},{"key":"pcbi.1012068.ref025","first-page":"6425","article-title":"An Introduction to Hypergraph Signal Processing","author":"S Barbarossa","year":"2016","journal-title":"Int Conf Acoust Spee"},{"key":"pcbi.1012068.ref026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1076-5670(04)31001-3","article-title":"Introduction to hypergraph theory and its use in engineering and image processing","volume":"131","author":"A. Bretto","year":"2004","journal-title":"Adv Imag Elect Phys"},{"issue":"1","key":"pcbi.1012068.ref027","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1109\/JIOT.2019.2950213","article-title":"Introducing Hypergraph Signal Processing: Theoretical Foundation and Practical Applications","volume":"7","author":"SY Zhang","year":"2020","journal-title":"Ieee Internet Things"},{"issue":"D1","key":"pcbi.1012068.ref028","doi-asserted-by":"crossref","first-page":"D777","DOI":"10.1093\/nar\/gkw1121","article-title":"COSMIC: somatic cancer genetics at high-resolution","volume":"45","author":"SA Forbes","year":"2017","journal-title":"Nucleic Acids Research"},{"issue":"22","key":"pcbi.1012068.ref029","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1093\/bioinformatics\/btv430","article-title":"Statistically identifying tumor suppressors and oncogenes from pan-cancer genome-sequencing data","volume":"31","author":"RD Kumar","year":"2015","journal-title":"Bioinformatics"},{"key":"pcbi.1012068.ref030","first-page":"3","article-title":"The mutational landscape of phosphorylation signaling in cancer","author":"J Reimand","year":"2013","journal-title":"Scientific Reports"},{"issue":"3","key":"pcbi.1012068.ref031","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.21037\/tcr-20-2568","article-title":"TTN\/TP53 mutation might act as the predictor for chemotherapy response in lung adenocarcinoma and lung squamous carcinoma patients","volume":"10","author":"D Xue","year":"2021","journal-title":"Transl Cancer Res"},{"issue":"11","key":"pcbi.1012068.ref032","article-title":"Single and Combined Use of Preoperative In fl ammatory Biomarkers and CA199 in Diagnosing Pancreatic Cancer","volume":"66","author":"Y Lu","year":"2020","journal-title":"Clin Lab"},{"issue":"W1","key":"pcbi.1012068.ref033","doi-asserted-by":"crossref","first-page":"W216","DOI":"10.1093\/nar\/gkac194","article-title":"DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update)","volume":"50","author":"BT Sherman","year":"2022","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1012068.ref034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"M Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"pcbi.1012068.ref035","article-title":"iGlioSub: an integrative transcriptomic and epigenomic classifier for glioblastoma molecular subtypes","volume":"14","author":"M Ensenyat-Mendez","year":"2021","journal-title":"Biodata Mining"},{"issue":"2","key":"pcbi.1012068.ref036","article-title":"Reclassification of Kidney Clear Cell Carcinoma Based on Immune Cell Gene-Related DNA CpG Pairs","volume":"9","author":"QZ Luo","year":"2021","journal-title":"Biomedicines"},{"key":"pcbi.1012068.ref037","first-page":"818","article-title":"Identification of three immune subtypes characterized by distinct tumor immune microenvironment and therapeutic response in stomach adenocarcinoma","author":"YM Zhu","year":"2022","journal-title":"Gene"},{"issue":"12","key":"pcbi.1012068.ref038","first-page":"12187","article-title":"Identification of immunological subtypes of hepatocellular carcinoma with expression profiling of immune-modulating genes","volume":"12","author":"D Cao","year":"2020"},{"issue":"1","key":"pcbi.1012068.ref039","first-page":"1","article-title":"The molecular portraits of breast tumors are conserved across microarray platforms","volume":"7","author":"Z Hu","year":"2006"},{"issue":"D1","key":"pcbi.1012068.ref040","doi-asserted-by":"crossref","first-page":"D1144","DOI":"10.1093\/nar\/gkaa1084","article-title":"Integration of the Drug-Gene Interaction Database (DGIdb 4.0) with open crowdsource efforts","volume":"49","author":"SL Freshour","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"W1","key":"pcbi.1012068.ref041","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gkab418","article-title":"GEPIA2021: integrating multiple deconvolution-based analysis into GEPIA","volume":"49","author":"C Li","year":"2021","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"pcbi.1012068.ref042","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/ng.2764","article-title":"The Cancer Genome Atlas Pan-Cancer analysis project","volume":"45","author":"Cancer Genome Atlas Research N","year":"2013","journal-title":"Nat Genet"},{"issue":"6","key":"pcbi.1012068.ref043","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","article-title":"Visualizing and interpreting cancer genomics data via the Xena platform","volume":"38","author":"MJ Goldman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"D1","key":"pcbi.1012068.ref044","doi-asserted-by":"crossref","first-page":"D447","DOI":"10.1093\/nar\/gku1003","article-title":"STRING v10: protein-protein interaction networks, integrated over the tree of life","volume":"43","author":"D Szklarczyk","year":"2015","journal-title":"Nucleic Acids Research"},{"key":"pcbi.1012068.ref045","first-page":"13","article-title":"Random Walks in Hypergraph","volume":"15","author":"A Bellaachia","year":"2021","journal-title":"Int J Educ Inf Tech"},{"issue":"11","key":"pcbi.1012068.ref046","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/nmeth.2642","article-title":"IntOGen-mutations identifies cancer drivers across tumor types","volume":"10","author":"A Gonzalez-Perez","year":"2013","journal-title":"Nature Methods"},{"issue":"10","key":"pcbi.1012068.ref047","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41568-020-0290-x","article-title":"A compendium of mutational cancer driver genes","volume":"20","author":"F Martinez-Jimenez","year":"2020","journal-title":"Nat Rev Cancer"}],"updated-by":[{"DOI":"10.1371\/journal.pcbi.1012068","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T00:00:00Z","timestamp":1715212800000}}],"container-title":["PLOS Computational Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012068","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,9]],"date-time":"2024-05-09T17:59:47Z","timestamp":1715277587000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pcbi.1012068"}},"subtitle":[],"editor":[{"given":"Sridhar","family":"Hannenhalli","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2024,4,29]]},"references-count":47,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2024,4,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pcbi.1012068","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pcbi.1012068","asserted-by":"object"}]},"ISSN":["1553-7358"],"issn-type":[{"value":"1553-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,29]]}}}